Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Oct 07, 2018 10:29am
76 Views
Post# 28759281

RE:RE:"End of debate".........I don't think so !

RE:RE:"End of debate".........I don't think so !Consider the reason why it is imperative that the market be assured that the company is financially sound or at least having the means to be.

After a month long PP they finished with $1.1 million of the $10 million they were seeking. A mining company also in the deal room had no problem successfully closing their $4.6 million PP. I'd hate to think that funding mining is more important than finding a cure for cancer.

A breakdown of the $1.1 million collected shows  $317,000 was provided by insiders with the remaining $783,000 coming from unknown sources. If we conclude that the majority of the money from the unknown sources was from wealthy " loyal shareholders " that had participated in past PPs then it further raises cause for concern.

So where is the outside interest that will be needed to fund the phase 2 trial? Maybe you should ask the people in charge of your money. That is after you folks have finished with your overbearing fluff opinions of the American political scene.
Bullboard Posts